Sorde, Laetitia, Spindeldreher, Sebastian and Karle, Anette (2017) Tregitopes and impaired antigen presentation: Drivers of the immunomodulatory effects of IVIg? European journal of immunology. ISSN 2050-4527

Abstract

Although intravenous immunoglobulin (IVIg) is commonly used in the clinic to treat various autoimmune and severe inflammatory diseases, the mode of action is not fully elucidated. This work investigates two proposed mechanisms: (1) the potential role of regulatory T-cell epitopes (Tregitopes) from the constant domain of IgG in the immunosuppressive function of IVIg, and (2) a potential impact of IVIg on the ability of antigen presenting cells (APCs) to present peptides. Investigation of the HLA class II peptide repertoire from IVIg-loaded dendritic cells (DCs) via MHC-associated peptide proteomics (MAPPs) revealed that numerous IgG-derived peptides were strongly presented all along the antibody sequence. Surprisingly, Tregitopes 167 and 289 did not show efficient natural presentation although they both bound to HLA class II when directly loaded as ‘naked’ peptides on human DCs. In addition, both Tregitopes could not reproduce the inhibitory effect of IVIg in a human in vitro T-cell proliferation assay as well as in vivo in mice. MAPPs data demonstrate that presentation of peptides from several antigens remained unchanged even when competed with high doses of IVIg, in both human and mouse. These data suggest that the effects mediated by IVIg are not caused by Tregitopes nor by impaired antigen presentation.

Item Type:	Article
Keywords:	IVIg; Tregitopes; HLA Class II; human DCs; immunomodulation; MAPPs; antigen presentation; CD4 T-cell proliferation; anti-OVA IgG; mouse
Date Deposited:	29 Nov 2017 00:45
Last Modified:	29 Nov 2017 00:45
URI:	https://oak.novartis.com/id/eprint/31581